
### [NCIT:C4711](http://purl.obolibrary.org/obo/NCIT_C4711)
**Label:** Borderline Cystadenoma

**Subclasses:** [NCIT:C4186](http://purl.obolibrary.org/obo/NCIT_C4186) (Borderline Papillary Mucinous Cystadenoma), [NCIT:C4177](http://purl.obolibrary.org/obo/NCIT_C4177) (Borderline Serous Cystadenoma), [NCIT:C4178](http://purl.obolibrary.org/obo/NCIT_C4178) (Borderline Papillary Cystadenoma), [NCIT:C4183](http://purl.obolibrary.org/obo/NCIT_C4183) (Borderline Papillary Serous Cystadenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C41457](http://purl.obolibrary.org/obo/NCIT_C41457) (Well-Circumscribed Lesion) 53.57%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.57%
- Thing 53.00%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 38.93%


